New York · 2025 Regular Session · Bill
A 7817: Relates to pharmacy benefits where a physician is authorized to dispense certain medications and practices medicine in the oncology setting
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 7817 is a bill introduced in the New York House on April 11, 2025. According to its official title, it concerns: Relates to pharmacy benefits where a physician is authorized to dispense certain medications and practices medicine in the oncology setting. Primary sponsor: Amy Paulin (Democratic). It lists 2 additional sponsors. Most recent recorded action (March 10, 2026): PRINT NUMBER 7817A.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to excepting situations where a physician or other licensed health care provider is authorized to dispense certain medications and is practicing medicine in the oncology setting and is dispensing oncology drugs or drugs related to an approved course of treatment used to manage symptoms related to cancer or cancer therapies.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Amy Paulin | Primary sponsor | Democratic | House | 88 |
| John McDonald | Co-sponsor | Democratic | House | 108 |
| Tommy John Schiavoni | Co-sponsor | Democratic/Working Families | House | 1 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- PRINT NUMBER 7817A
- AMEND AND RECOMMIT TO HEALTH
- REFERRED TO HEALTH
- REFERRED TO HEALTH